Active — Not RecruitingNot Applicable

COVID-19: Respiratory and Sleep Follow-up

France395 participantsStarted 2020-06-06

Plain-language summary

The current project is a prospective, multicentric cohort study aiming at a multidisciplinary assessment (pulmonary, cardiometabolic, sleep and mental health) of the consequences of infection by SARS-CoV-2, 3 months after the diagnosis in order to better characterize these complications. 400 patients with a positive diagnosis of SARS-CoV-2 will be included in the study 3 months after their diagnosis: They will be followed at 6 months, 1 year, 3 years, and 5 years, as function of their after-effects discovered at 3 months and their evolution.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or Female, aged \> 18 years * With a positive diagnosis for SARS-COVID-19, confirmed by RT-PCR or with compatible symptoms * Signed informed consent by patient * Affiliated to a French social and health insurance system or equivalent * For biological collection: patient eligible for sampling (weight \>50kg and hemoglobin \>7g/dL) and signed inform consent for collection Exclusion Criteria: * Pregnant or breastfeeding women * Prisoners or patients who require protection by the law * Patients not affiliated to a French social and health insurance system or equivalent * Ages \<18 years * Diagnosis of infection by other pathogen than SARS-COVID-19 or no indication of infection by COVID-19

What they're measuring

Diffusion Capacity for Carbon Monoxide (CO) 3 months after COVID diagnosis

Timeframe: 3 months after COVID diagnosis

Trial details

NCT IDNCT04406324

SponsorUniversity Hospital, Grenoble

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-07

View on ClinicalTrials.gov More COVID-19 trials